Pharmaceutical Executive
Speed to market is crucial to the success of launching new products and therapies.
Don Steele
Advertisement
Articles by Don Steele
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
3
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
4
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
5